M&A Deal Summary |
|
|---|---|
| Date | 2022-12-01 |
| Target | Brightech |
| Sector | Information Services |
| Buyer(s) | Everest Clinical Research |
| Deal Type | Add-on Acquisition |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2004 |
| Sector | Life Science |
Everest Clinical Research is a contract research organization (“CRO”) providing a comprehensive suite of mission-critical clinical research services to the worldwide pharmaceutical, biotechnology, and medical device industries across Phase I-IV trials. Everest Clinical Research was founded in 2004 and is based in Markham, Ontario.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 2 |
| Sector: Information Services M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 2 |
| State: New Jersey M&A | 1 of 1 |
| Country: United States M&A | 1 of 2 |
| Year: 2022 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2023-11-07 |
August
Scarsdale, New York, United States August is a European CRO that provides Clinical Trial Services (“CTS”) and Pharmacovigilance (“PV”) services to pharmaceutical and biotechnology clients. The Company has worked on over 120 projects for Phase I-IV clinical trials across multiple therapeutic areas including cardiovascular, infectious disease, oncology, and rare disease. August is based in Scarsdale, New York. |
Buy | - |
